Determining Risks for Cannabis Use Disorder in the Face of Changing Legal Policies.
bioecological model
cannabis use disorder
cultural
legalization
public health
risk
Journal
Current addiction reports
ISSN: 2196-2952
Titre abrégé: Curr Addict Rep
Pays: Switzerland
ID NLM: 101623508
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
entrez:
14
12
2020
pubmed:
15
12
2020
medline:
15
12
2020
Statut:
ppublish
Résumé
This review aims to summarize and critically evaluate the current literature on the associations between individual and socio-cultural factors that increase risk for cannabis use disorder (CUD), and policy change. Epidemiological studies show that areas with permissive legal cannabis climates are associated with greater individual risk factors for CUD. This includes: (1) higher rates of edible consumption and vaping, (2) higher delta-9-tetrahydrocannabinol (THC) potency and lower cannabidiol (CBD) levels, and, (3) younger age of initiation of use. A change in the socio-cultural level, such as shifts in the legalization of cannabis, could interact with individual-level factors in their associations with CUD. There is currently a lack of empirical studies that evaluate this interaction. We propose that future research consider a bioecological framework for CUD to allow for a comprehensive understanding of the effects of legal climate that could inform policy and clinical practice.
Identifiants
pubmed: 33312839
doi: 10.1007/s40429-019-00288-6
pmc: PMC7731876
mid: NIHMS1541527
doi:
Types de publication
Journal Article
Langues
eng
Pagination
466-477Subventions
Organisme : NIDA NIH HHS
ID : R01 DA042490
Pays : United States
Déclaration de conflit d'intérêts
Conflict of Interest Mackenzie Taylor, Janna Cousijn, and Francesca M. Filbey declare that they have no conflicts of interest.
Références
Subst Abus. 2014;35(4):331-5
pubmed: 25127003
Addict Behav. 2007 Sep;32(9):1957-63
pubmed: 17258398
J Am Acad Child Adolesc Psychiatry. 1997 Jan;36(1):21-9
pubmed: 9000777
Neuropsychopharmacology. 2006 Dec;31(12):2748-57
pubmed: 16936704
Addiction. 2000 Nov;95(11):1679-90
pubmed: 11219371
Subst Use Misuse. 2019;54(4):670-680
pubmed: 30663487
J Child Psychol Psychiatry. 2004 May;45(4):707-18
pubmed: 15056303
Aust N Z J Psychiatry. 2000 Jun;34(3):468-75
pubmed: 10881971
Neurotherapeutics. 2015 Oct;12(4):816-24
pubmed: 26311150
PLoS One. 2015 Nov 25;10(11):e0143562
pubmed: 26605550
Drug Alcohol Depend. 2008 Jan 1;92(1-3):239-47
pubmed: 17888588
Acta Psychiatr Scand. 2011 Jun;123(6):485-92
pubmed: 21231925
Health Rep. 2019 Jun 19;30(6):3-13
pubmed: 31216047
Curr Opin Psychiatry. 2007 Jul;20(4):393-7
pubmed: 17551355
Drug Alcohol Depend. 2012 Jan 1;120(1-3):22-7
pubmed: 22099393
Addiction. 2006 Jun;101(6):801-12
pubmed: 16696624
Prog Neuropsychopharmacol Biol Psychiatry. 2018 Mar 2;82:95-106
pubmed: 29191570
Drug Alcohol Depend. 2007 Apr;88 Suppl 1:S60-70
pubmed: 17257779
J Subst Abuse Treat. 2009 Jun;36(4):400-13
pubmed: 19004601
CMAJ Open. 2019 Jun 14;7(2):E399-E404
pubmed: 31201176
J Subst Abuse Treat. 2013 Apr;44(4):438-43
pubmed: 23098380
Drug Alcohol Depend. 2002 Sep 1;68(1):49-64
pubmed: 12167552
J Psychiatr Res. 2015 May;64:79-87
pubmed: 25795093
Eur Arch Psychiatry Clin Neurosci. 2019 Feb;269(1):5-15
pubmed: 30671616
Eur Neuropsychopharmacol. 2016 Mar;26(3):493-505
pubmed: 26775742
Psychol Addict Behav. 2015 Sep;29(3):633-8
pubmed: 26415060
J Subst Abuse Treat. 2017 Sep;80:45-51
pubmed: 28755772
J Stud Alcohol Drugs. 2016 Sep;77(5):684-7
pubmed: 27588524
Addiction. 2010 Mar;105(3):417-30
pubmed: 20402985
J Psychopharmacol. 2016 Feb;30(2):152-8
pubmed: 26645206
Psychol Serv. 2012 Nov;9(4):404-416
pubmed: 22564034
Int J Drug Policy. 2016 Oct;36:141-7
pubmed: 26992484
Psychol Med. 2006 Oct;36(10):1447-60
pubmed: 16854249
Psychopharmacology (Berl). 2011 Mar;214(1):17-31
pubmed: 20596857
Addiction. 1999 Nov;94(11):1679-94
pubmed: 10892007
PLoS One. 2012;7(6):e39243
pubmed: 22745721
Addiction. 2001 Nov;96(11):1603-14
pubmed: 11784457
Dev Psychopathol. 2017 Oct;29(4):1253-1266
pubmed: 28031069
Addict Behav. 2019 Nov;98:106015
pubmed: 31233947
Addict Sci Clin Pract. 2016 Apr 26;11(1):9
pubmed: 27117064
PLoS Med. 2008 Jul 1;5(7):e141
pubmed: 18597549
Arch Gen Psychiatry. 2002 Dec;59(12):1125-32
pubmed: 12470129
Transl Psychiatry. 2016 Feb 16;6:e738
pubmed: 26882038
Drug Alcohol Depend. 2007 Sep 6;90(1):2-11
pubmed: 17367959
Hum Brain Mapp. 2014 May;35(5):2470-82
pubmed: 24038570
Hum Mol Genet. 2017 Jul 1;26(13):2462-2471
pubmed: 28402427
PLoS One. 2012;7(11):e49432
pubmed: 23209577
Am J Drug Alcohol Abuse. 2009;35(6):399-407
pubmed: 20014907
Drug Alcohol Rev. 2005 Nov;24(6):483-8
pubmed: 16361204
Schizophr Bull. 2015 Sep;41(5):1171-82
pubmed: 25829376
Addiction. 2015 Dec;110(12):1941-50
pubmed: 26234170
Curr Addict Rep. 2017 Jun;4(2):100-109
pubmed: 29062679
Int J Drug Policy. 2014 Mar;25(2):308-19
pubmed: 24502887
J Psychopharmacol. 2015 Nov;29(11):1146-51
pubmed: 26464454
Addict Behav. 2010 Feb;35(2):91-4
pubmed: 19773127
Neuropsychopharmacology. 2002 Apr;26(4):479-88
pubmed: 11927172
Addiction. 2016 Oct;111(10):1764-73
pubmed: 27082374
Aust N Z J Psychiatry. 2012 Dec;46(12):1182-92
pubmed: 22984111
J Adolesc. 1990 Dec;13(4):327-39
pubmed: 2074287
Harm Reduct J. 2015 Oct 14;12:46
pubmed: 26467203
Biol Psychiatry. 2016 Apr 1;79(7):613-9
pubmed: 26903403
Biol Psychiatry. 2005 May 15;57(10):1117-27
pubmed: 15866551
Drug Alcohol Rev. 2004 Dec;23(4):381-90
pubmed: 15763742
Pediatrics. 2004 Jun;113(6):e632-8
pubmed: 15173547
Clin Psychol Rev. 2011 Apr;31(3):328-41
pubmed: 21382538
JAMA. 2003 Jan 22-29;289(4):427-33
pubmed: 12533121
Cent Afr J Med. 1994 Aug;40(8):207-12
pubmed: 7812998
J Child Psychol Psychiatry. 2013 Apr;54(4):348-66
pubmed: 23215898
N Z Med J. 1997 Mar 14;110(1039):68-70
pubmed: 9137298
Am J Public Health. 2004 May;94(5):836-42
pubmed: 15117709
Drug Alcohol Depend. 2014 Mar 1;136:162-5
pubmed: 24412475
Am J Psychiatry. 2004 Mar;161(3):501-6
pubmed: 14992976
Am J Psychiatry. 2016 Jun 1;173(6):588-99
pubmed: 26940807
Addiction. 2006 Feb;101(2):241-51
pubmed: 16445553